Evidence map›Paper›PMID 24035561›Full record

ArticleSchizophrenia research2013

Proteoglycan abnormalities in olfactory epithelium tissue from subjects diagnosed with schizophrenia.

Harry Pantazopoulos, Anne Boyer-Boiteau, Eric H Holbrook, Woochan Jang, Chang-Gyu Hahn, Steven E Arnold, Sabina Berretta

Open access · hybridAbstract read
In one paragraph

Article in Schizophrenia research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Matrisome changes in Parkinson's disease.Analytical and bioanalytical chemistry · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Proteomics, Glycomics, and Glycoproteomics of Matrisome Molecules.Molecular & cellular proteomics : MCP · 2019
    Review
  11. Article
  12. Article
  13. The tetrapartite synapse: a key concept in the pathophysiology of schizophrenia.European psychiatry : the journal of the Association of European Psychiatrists · 2018
    Review
  14. Disrupted Olfactory Integration in Schizophrenia: Functional Connectivity Study.The international journal of neuropsychopharmacology · 2017
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Office-based olfactory mucosa biopsies.International forum of allergy & rhinology · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Harry PantazopoulosDepartment of Psychiatry, Harvard Medical School, 25 Shattuck St., Boston, MA 02115, USA; Translational Neuroscience Laboratory, McLean Hospital, 115 Mill St., Belmont, MA 02478, USA.
Anne Boyer-Boiteau
Eric H Holbrook
Woochan Jang
Chang-Gyu Hahn
Steven E Arnold
Sabina Berretta
McLean Hospital · USUniversity of Pennsylvania · USHarvard University · USMassachusetts Eye and Ear Infirmary · USTufts University · US

Funding

Olfactory Evoked Potentials and Developmental Neuropathology in SchizophreniaR01MH059852 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI HAHN, CHANG-GYU, TURETSKY, BRUCE I · 1999 to 2015
$6.6M
Extracellular anomalies in Schizophrenia: from molecules to symptomsR01MH091348 · NIMH · MCLEAN HOSPITAL · PI BERRETTA, SABINA · 2011 to 2015
$3.1M
Disruption of Extracellular Matrix-Glial Interactions in SchizophreniaR01MH086522 · NIMH · MCLEAN HOSPITAL · PI BERRETTA, SABINA · 2011 to 2015
$2.0M
NIMH NIH HHS R01 MH059852NIMH NIH HHS R01 MH086522NIMH NIH HHS R01 MH091348NIMH NIH HHS R01-MH091348
6 · The paper itself

Abstract

Emerging evidence points to proteoglycan abnormalities in the pathophysiology of schizophrenia (SZ). In particular, markedly abnormal expression of chondroitin sulfate proteoglycans (CSPGs), key components of the extracellular matrix, was observed in the medial temporal lobe. CSPG functions, including regulation of neuronal differentiation and migration, are highly relevant to the pathophysiology of SZ. CSPGs may exert similar functions in the olfactory epithelium (OE), a continuously regenerating neural tissue that shows cell and molecular abnormalities in SZ. We tested the hypothesis that CSPG expression in OE may be altered in SZ. CSPG-positive cells in postmortem OE from non-psychiatric control (n=9) and SZ (n=10) subjects were counted using computer-assisted light microscopy. 'Cytoplasmic' CSPG (c-CSPG) labeling was detected in sustentacular cells and some olfactory receptor neurons (c-CSPG+ORNs), while 'pericellular' CSPG (p-CSPG) labeling was found in basal cells and some ORNs (p-CSPG+ORNs). Dual labeling for CSPG and markers for mature and immature ORNs suggests that c-CSPG+ORNs correspond to mature ORNs, and p-CSPG+ORNs to immature ORNs. Previous studies in the same cohort demonstrated that densities of mature ORNs were unaltered (Arnold et al., 2001). In the present study, numerical densities of c-CSPG+ORNs were significantly decreased in SZ (p<0.025; 99.32% decrease), suggesting a reduction of CSPG expression in mature ORNs. Previous studies showed a striking increase in the ratios of immature neurons with respect to basal cells. In this study, we find that the ratio of p-CSPG+ORNs/CSPG+basal cells was significantly increased (p=0.03) in SZ, while numerical density changes of p-CSPG+ORNs (110.71% increase) or CSPG+basal cells (53.71% decrease), did not reach statistical significance. Together, these results indicate that CSPG abnormalities are present in the OE of SZ and specifically point to a reduction of CSPG expression in mature ORNs in SZ. Given the role CSPGs play in OE cell differentiation and axon guidance, we suggest that altered CSPG expression may contribute to ORN lineage dysregulation, and olfactory identification abnormalities, observed in SZ.

Indexed as

AdultAgedAged, 80 and overBiopsyCase-Control StudiesFemaleGAP-43 ProteinHumansMaleMiddle AgedOlfactory Marker ProteinOlfactory MucosaPlant LectinsProteoglycansReceptor-Like Protein Tyrosine Phosphatases, Class 5Receptors, Cell Surfacechondroitin sulfate proteoglycan receptor, humanGAP-43 ProteinOlfactory Marker ProteinPlant LectinsProteoglycansReceptor-Like Protein Tyrosine Phosphatases, Class 5Receptors, Cell SurfaceReceptors, N-AcetylglucosamineVersicanswisteria lectinbovine albumin serumBSAc-CSPGchlorpromazine-equivalentchondroitin sulfate proteoglycanChondroitin sulfate proteoglycansCPZCSPGcytoplasmic chondroitin sulfate proteoglycanExtracellular matrixGAGGAP43glycosaminoglycangrowth associate protein 43neural stem/cell progenitorNSCPOEolfactory epitheliumOlfactory epitheliumolfactory marker proteinolfactory receptor neuronOMPORNPBS–Txp-CSPGpericellular chondroitin sulfate proteoglycanphosphate buffer–Triton XPMIPostmortempostmortem time intervalREreceptor tyrosine phosphatase zetarespiratory epitheliumRPTPzschizophreniaSchizophreniaSCIDStructured Clinical Interview for DSM DisordersSZWFAWisteria floribunda agglutinin

Identifiers

PMID24035561
PMCPMC4215560
OpenAlexW2020188570

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.